E-Nose: Diagnostic Tool for Pleural TB
Diagnostic Utility of the E-Nose for Pleural TB
Sponsor: Foundation for Research in Mycobacteria (FUNDAIM)
Listed as NCT02765087, this NA trial focuses on Tuberculosis, Pleural and remains ongoing. Sponsored by Foundation for Research in Mycobacteria (FUNDAIM), it has been updated 8 times since 2015, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status NA
-
Dec 2019 — Jan 2021 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Feb 2019 — Dec 2019 [monthly]
Recruiting NA
▶ Show 3 earlier versions
-
Jun 2018 — Feb 2019 [monthly]
Recruiting NA
-
Dec 2017 — Jun 2018 [monthly]
Recruiting NA
Status: Active Not Recruiting → Recruiting
-
Jan 2017 — Dec 2017 [monthly]
Active Not Recruiting NA
First recorded
Jan 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Foundation for Research in Mycobacteria (FUNDAIM)
- The ENose Company, Zutphen, Netherlands
- Universidad Central de Venezuela
For direct contact, visit the study record on ClinicalTrials.gov .